Industry Research Reports

Home > Reports > Pharma & Healthcare > Global New Drug for Alzheimer's Treatment Market Research Report 2024

Global New Drug for Alzheimer's Treatment Market Research Report 2024

Industry: Pharma & Healthcare

Published: 2024-07-17

Pages: 84 Pages

Report ld: 3244481

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global New Drug for Alzheimer's Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for New Drug for Alzheimer's Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for New Drug for Alzheimer's Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of New Drug for Alzheimer's Treatment include Biogen, Eisai, Eli Lilly, Neurimmune, Roche, AstraZeneca, Green Valley, Vivoryon, Simcere, Johnson and Johnson, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for New Drug for Alzheimer's Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding New Drug for Alzheimer's Treatment.

The New Drug for Alzheimer's Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global New Drug for Alzheimer's Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the New Drug for Alzheimer's Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Report Metric
Details
Report Title
Global New Drug for Alzheimer's Treatment Market Research Report 2024
Global New Drug for Alzheimer's Treatment Companies Covered
Biogen, Eisai, Eli Lilly, Neurimmune, Roche, AstraZeneca, Green Valley, Vivoryon, Simcere, Johnson and Johnson
Global New Drug for Alzheimer's Treatment Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global New Drug for Alzheimer's Treatment Market, Segment by Type
AChE Target

Aβ Target

BChE Target

Others
Global New Drug for Alzheimer's Treatment Market, Segment by Application
Preclinical Stage

Mild Cognitive Impairment Stage

Dementia Stage
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of New Drug for Alzheimer's Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3:  Sales, revenue of New Drug for Alzheimer's Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Table of Contents

 1 New Drug for Alzheimer's Treatment Market Overview
    1.1 Product Definition
    1.2 New Drug for Alzheimer's Treatment by Type
        1.2.1 Global New Drug for Alzheimer's Treatment Market Value Comparison by Type (2024-2030)
        1.2.2 AChE Target
        1.2.3 Aβ Target
        1.2.4 BChE Target
        1.2.5 Others
    1.3 New Drug for Alzheimer's Treatment by Application
        1.3.1 Global New Drug for Alzheimer's Treatment Market Value by Application (2024-2030)
        1.3.2 Preclinical Stage
        1.3.3 Mild Cognitive Impairment Stage
        1.3.4 Dementia Stage
    1.4 Global New Drug for Alzheimer's Treatment Market Size Estimates and Forecasts
        1.4.1 Global New Drug for Alzheimer's Treatment Revenue 2019-2030
        1.4.2 Global New Drug for Alzheimer's Treatment Sales 2019-2030
        1.4.3 Global New Drug for Alzheimer's Treatment Market Average Price (2019-2030)
    1.5 Assumptions and Limitations

 2 New Drug for Alzheimer's Treatment Market Competition by Manufacturers
    2.1 Global New Drug for Alzheimer's Treatment Sales Market Share by Manufacturers (2019-2024)
    2.2 Global New Drug for Alzheimer's Treatment Revenue Market Share by Manufacturers (2019-2024)
    2.3 Global New Drug for Alzheimer's Treatment Average Price by Manufacturers (2019-2024)
    2.4 Global Key Players of New Drug for Alzheimer's Treatment, Industry Ranking, 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of New Drug for Alzheimer's Treatment, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of New Drug for Alzheimer's Treatment, Product Type & Application
    2.7 Global Key Manufacturers of New Drug for Alzheimer's Treatment, Date of Enter into This Industry
    2.8 Global New Drug for Alzheimer's Treatment Market Competitive Situation and Trends
        2.8.1 Global New Drug for Alzheimer's Treatment Market Concentration Rate
        2.8.2 The Global 5 and 10 Largest New Drug for Alzheimer's Treatment Players Market Share by Revenue
        2.8.3 Global New Drug for Alzheimer's Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Global New Drug for Alzheimer's Treatment Market Scenario by Region
    3.1 Global New Drug for Alzheimer's Treatment Market Size by Region: 2019 Versus 2023 Versus 2030
    3.2 Global New Drug for Alzheimer's Treatment Sales by Region: 2019-2030
        3.2.1 Global New Drug for Alzheimer's Treatment Sales by Region: 2019-2024
        3.2.2 Global New Drug for Alzheimer's Treatment Sales by Region: 2025-2030
    3.3 Global New Drug for Alzheimer's Treatment Revenue by Region: 2019-2030
        3.3.1 Global New Drug for Alzheimer's Treatment Revenue by Region: 2019-2024
        3.3.2 Global New Drug for Alzheimer's Treatment Revenue by Region: 2025-2030
    3.4 North America New Drug for Alzheimer's Treatment Market Facts & Figures by Country
        3.4.1 North America New Drug for Alzheimer's Treatment Market Size by Country: 2019 VS 2023 VS 2030
        3.4.2 North America New Drug for Alzheimer's Treatment Sales by Country (2019-2030)
        3.4.3 North America New Drug for Alzheimer's Treatment Revenue by Country (2019-2030)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe New Drug for Alzheimer's Treatment Market Facts & Figures by Country
        3.5.1 Europe New Drug for Alzheimer's Treatment Market Size by Country: 2019 VS 2023 VS 2030
        3.5.2 Europe New Drug for Alzheimer's Treatment Sales by Country (2019-2030)
        3.5.3 Europe New Drug for Alzheimer's Treatment Revenue by Country (2019-2030)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific New Drug for Alzheimer's Treatment Market Facts & Figures by Region
        3.6.1 Asia Pacific New Drug for Alzheimer's Treatment Market Size by Region: 2019 VS 2023 VS 2030
        3.6.2 Asia Pacific New Drug for Alzheimer's Treatment Sales by Region (2019-2030)
        3.6.3 Asia Pacific New Drug for Alzheimer's Treatment Revenue by Region (2019-2030)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Southeast Asia
    3.7 Latin America New Drug for Alzheimer's Treatment Market Facts & Figures by Country
        3.7.1 Latin America New Drug for Alzheimer's Treatment Market Size by Country: 2019 VS 2023 VS 2030
        3.7.2 Latin America New Drug for Alzheimer's Treatment Sales by Country (2019-2030)
        3.7.3 Latin America New Drug for Alzheimer's Treatment Revenue by Country
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
        3.7.7 Colombia
    3.8 Middle East and Africa New Drug for Alzheimer's Treatment Market Facts & Figures by Country
        3.8.1 Middle East and Africa New Drug for Alzheimer's Treatment Market Size by Country: 2019 VS 2023 VS 2030
        3.8.2 Middle East and Africa New Drug for Alzheimer's Treatment Sales by Country (2019-2030)
        3.8.3 Middle East and Africa New Drug for Alzheimer's Treatment Revenue by Country
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global New Drug for Alzheimer's Treatment Sales by Type (2019-2030)
        4.1.1 Global New Drug for Alzheimer's Treatment Sales by Type (2019-2024)
        4.1.2 Global New Drug for Alzheimer's Treatment Sales by Type (2025-2030)
        4.1.3 Global New Drug for Alzheimer's Treatment Sales Market Share by Type (2019-2030)
    4.2 Global New Drug for Alzheimer's Treatment Revenue by Type (2019-2030)
        4.2.1 Global New Drug for Alzheimer's Treatment Revenue by Type (2019-2024)
        4.2.2 Global New Drug for Alzheimer's Treatment Revenue by Type (2025-2030)
        4.2.3 Global New Drug for Alzheimer's Treatment Revenue Market Share by Type (2019-2030)
    4.3 Global New Drug for Alzheimer's Treatment Price by Type (2019-2030)

 5 Segment by Application
    5.1 Global New Drug for Alzheimer's Treatment Sales by Application (2019-2030)
        5.1.1 Global New Drug for Alzheimer's Treatment Sales by Application (2019-2024)
        5.1.2 Global New Drug for Alzheimer's Treatment Sales by Application (2025-2030)
        5.1.3 Global New Drug for Alzheimer's Treatment Sales Market Share by Application (2019-2030)
    5.2 Global New Drug for Alzheimer's Treatment Revenue by Application (2019-2030)
        5.2.1 Global New Drug for Alzheimer's Treatment Revenue by Application (2019-2024)
        5.2.2 Global New Drug for Alzheimer's Treatment Revenue by Application (2025-2030)
        5.2.3 Global New Drug for Alzheimer's Treatment Revenue Market Share by Application (2019-2030)
    5.3 Global New Drug for Alzheimer's Treatment Price by Application (2019-2030)

 6 Key Companies Profiled
    6.1 Biogen
        6.1.1 Biogen Company Information
        6.1.2 Biogen Description and Business Overview
        6.1.3 Biogen New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        6.1.4 Biogen New Drug for Alzheimer's Treatment Product Portfolio
        6.1.5 Biogen Recent Developments/Updates
    6.2 Eisai
        6.2.1 Eisai Company Information
        6.2.2 Eisai Description and Business Overview
        6.2.3 Eisai New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        6.2.4 Eisai New Drug for Alzheimer's Treatment Product Portfolio
        6.2.5 Eisai Recent Developments/Updates
    6.3 Eli Lilly
        6.3.1 Eli Lilly Company Information
        6.3.2 Eli Lilly Description and Business Overview
        6.3.3 Eli Lilly New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        6.3.4 Eli Lilly New Drug for Alzheimer's Treatment Product Portfolio
        6.3.5 Eli Lilly Recent Developments/Updates
    6.4 Neurimmune
        6.4.1 Neurimmune Company Information
        6.4.2 Neurimmune Description and Business Overview
        6.4.3 Neurimmune New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 Neurimmune New Drug for Alzheimer's Treatment Product Portfolio
        6.4.5 Neurimmune Recent Developments/Updates
    6.5 Roche
        6.5.1 Roche Company Information
        6.5.2 Roche Description and Business Overview
        6.5.3 Roche New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        6.5.4 Roche New Drug for Alzheimer's Treatment Product Portfolio
        6.5.5 Roche Recent Developments/Updates
    6.6 AstraZeneca
        6.6.1 AstraZeneca Company Information
        6.6.2 AstraZeneca Description and Business Overview
        6.6.3 AstraZeneca New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        6.6.4 AstraZeneca New Drug for Alzheimer's Treatment Product Portfolio
        6.6.5 AstraZeneca Recent Developments/Updates
    6.7 Green Valley
        6.7.1 Green Valley Company Information
        6.7.2 Green Valley Description and Business Overview
        6.7.3 Green Valley New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        6.7.4 Green Valley New Drug for Alzheimer's Treatment Product Portfolio
        6.7.5 Green Valley Recent Developments/Updates
    6.8 Vivoryon
        6.8.1 Vivoryon Company Information
        6.8.2 Vivoryon Description and Business Overview
        6.8.3 Vivoryon New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        6.8.4 Vivoryon New Drug for Alzheimer's Treatment Product Portfolio
        6.8.5 Vivoryon Recent Developments/Updates
    6.9 Simcere
        6.9.1 Simcere Company Information
        6.9.2 Simcere Description and Business Overview
        6.9.3 Simcere New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        6.9.4 Simcere New Drug for Alzheimer's Treatment Product Portfolio
        6.9.5 Simcere Recent Developments/Updates
    6.10 Johnson and Johnson
        6.10.1 Johnson and Johnson Company Information
        6.10.2 Johnson and Johnson Description and Business Overview
        6.10.3 Johnson and Johnson New Drug for Alzheimer's Treatment Sales, Revenue and Gross Margin (2019-2024)
        6.10.4 Johnson and Johnson New Drug for Alzheimer's Treatment Product Portfolio
        6.10.5 Johnson and Johnson Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 New Drug for Alzheimer's Treatment Industry Chain Analysis
    7.2 New Drug for Alzheimer's Treatment Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 New Drug for Alzheimer's Treatment Production Mode & Process
    7.4 New Drug for Alzheimer's Treatment Sales and Marketing
        7.4.1 New Drug for Alzheimer's Treatment Sales Channels
        7.4.2 New Drug for Alzheimer's Treatment Distributors
    7.5 New Drug for Alzheimer's Treatment Customers

 8 New Drug for Alzheimer's Treatment Market Dynamics
    8.1 New Drug for Alzheimer's Treatment Industry Trends
    8.2 New Drug for Alzheimer's Treatment Market Drivers
    8.3 New Drug for Alzheimer's Treatment Market Challenges
    8.4 New Drug for Alzheimer's Treatment Market Restraints

 9 Research Findings and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Table of Figures

List of Tables
 Table 1. Global New Drug for Alzheimer's Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global New Drug for Alzheimer's Treatment Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global New Drug for Alzheimer's Treatment Market Competitive Situation by Manufacturers in 2023
 Table 4. Global New Drug for Alzheimer's Treatment Sales (K Dose) of Key Manufacturers (2019-2024)
 Table 5. Global New Drug for Alzheimer's Treatment Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global New Drug for Alzheimer's Treatment Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global New Drug for Alzheimer's Treatment Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market New Drug for Alzheimer's Treatment Average Price (US$/Dose) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of New Drug for Alzheimer's Treatment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of New Drug for Alzheimer's Treatment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of New Drug for Alzheimer's Treatment, Product Type & Application
 Table 12. Global Key Manufacturers of New Drug for Alzheimer's Treatment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global New Drug for Alzheimer's Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Drug for Alzheimer's Treatment as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global New Drug for Alzheimer's Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global New Drug for Alzheimer's Treatment Sales by Region (2019-2024) & (K Dose)
 Table 18. Global New Drug for Alzheimer's Treatment Sales Market Share by Region (2019-2024)
 Table 19. Global New Drug for Alzheimer's Treatment Sales by Region (2025-2030) & (K Dose)
 Table 20. Global New Drug for Alzheimer's Treatment Sales Market Share by Region (2025-2030)
 Table 21. Global New Drug for Alzheimer's Treatment Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global New Drug for Alzheimer's Treatment Revenue Market Share by Region (2019-2024)
 Table 23. Global New Drug for Alzheimer's Treatment Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global New Drug for Alzheimer's Treatment Revenue Market Share by Region (2025-2030)
 Table 25. North America New Drug for Alzheimer's Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America New Drug for Alzheimer's Treatment Sales by Country (2019-2024) & (K Dose)
 Table 27. North America New Drug for Alzheimer's Treatment Sales by Country (2025-2030) & (K Dose)
 Table 28. North America New Drug for Alzheimer's Treatment Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America New Drug for Alzheimer's Treatment Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe New Drug for Alzheimer's Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe New Drug for Alzheimer's Treatment Sales by Country (2019-2024) & (K Dose)
 Table 32. Europe New Drug for Alzheimer's Treatment Sales by Country (2025-2030) & (K Dose)
 Table 33. Europe New Drug for Alzheimer's Treatment Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe New Drug for Alzheimer's Treatment Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific New Drug for Alzheimer's Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific New Drug for Alzheimer's Treatment Sales by Region (2019-2024) & (K Dose)
 Table 37. Asia Pacific New Drug for Alzheimer's Treatment Sales by Region (2025-2030) & (K Dose)
 Table 38. Asia Pacific New Drug for Alzheimer's Treatment Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific New Drug for Alzheimer's Treatment Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America New Drug for Alzheimer's Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America New Drug for Alzheimer's Treatment Sales by Country (2019-2024) & (K Dose)
 Table 42. Latin America New Drug for Alzheimer's Treatment Sales by Country (2025-2030) & (K Dose)
 Table 43. Latin America New Drug for Alzheimer's Treatment Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America New Drug for Alzheimer's Treatment Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa New Drug for Alzheimer's Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa New Drug for Alzheimer's Treatment Sales by Country (2019-2024) & (K Dose)
 Table 47. Middle East and Africa New Drug for Alzheimer's Treatment Sales by Country (2025-2030) & (K Dose)
 Table 48. Middle East and Africa New Drug for Alzheimer's Treatment Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa New Drug for Alzheimer's Treatment Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global New Drug for Alzheimer's Treatment Sales (K Dose) by Type (2019-2024)
 Table 51. Global New Drug for Alzheimer's Treatment Sales (K Dose) by Type (2025-2030)
 Table 52. Global New Drug for Alzheimer's Treatment Sales Market Share by Type (2019-2024)
 Table 53. Global New Drug for Alzheimer's Treatment Sales Market Share by Type (2025-2030)
 Table 54. Global New Drug for Alzheimer's Treatment Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global New Drug for Alzheimer's Treatment Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global New Drug for Alzheimer's Treatment Revenue Market Share by Type (2019-2024)
 Table 57. Global New Drug for Alzheimer's Treatment Revenue Market Share by Type (2025-2030)
 Table 58. Global New Drug for Alzheimer's Treatment Price (US$/Dose) by Type (2019-2024)
 Table 59. Global New Drug for Alzheimer's Treatment Price (US$/Dose) by Type (2025-2030)
 Table 60. Global New Drug for Alzheimer's Treatment Sales (K Dose) by Application (2019-2024)
 Table 61. Global New Drug for Alzheimer's Treatment Sales (K Dose) by Application (2025-2030)
 Table 62. Global New Drug for Alzheimer's Treatment Sales Market Share by Application (2019-2024)
 Table 63. Global New Drug for Alzheimer's Treatment Sales Market Share by Application (2025-2030)
 Table 64. Global New Drug for Alzheimer's Treatment Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global New Drug for Alzheimer's Treatment Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global New Drug for Alzheimer's Treatment Revenue Market Share by Application (2019-2024)
 Table 67. Global New Drug for Alzheimer's Treatment Revenue Market Share by Application (2025-2030)
 Table 68. Global New Drug for Alzheimer's Treatment Price (US$/Dose) by Application (2019-2024)
 Table 69. Global New Drug for Alzheimer's Treatment Price (US$/Dose) by Application (2025-2030)
 Table 70. Biogen Company Information
 Table 71. Biogen Description and Business Overview
 Table 72. Biogen New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 73. Biogen New Drug for Alzheimer's Treatment Product
 Table 74. Biogen Recent Developments/Updates
 Table 75. Eisai Company Information
 Table 76. Eisai Description and Business Overview
 Table 77. Eisai New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 78. Eisai New Drug for Alzheimer's Treatment Product
 Table 79. Eisai Recent Developments/Updates
 Table 80. Eli Lilly Company Information
 Table 81. Eli Lilly Description and Business Overview
 Table 82. Eli Lilly New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 83. Eli Lilly New Drug for Alzheimer's Treatment Product
 Table 84. Eli Lilly Recent Developments/Updates
 Table 85. Neurimmune Company Information
 Table 86. Neurimmune Description and Business Overview
 Table 87. Neurimmune New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 88. Neurimmune New Drug for Alzheimer's Treatment Product
 Table 89. Neurimmune Recent Developments/Updates
 Table 90. Roche Company Information
 Table 91. Roche Description and Business Overview
 Table 92. Roche New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 93. Roche New Drug for Alzheimer's Treatment Product
 Table 94. Roche Recent Developments/Updates
 Table 95. AstraZeneca Company Information
 Table 96. AstraZeneca Description and Business Overview
 Table 97. AstraZeneca New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 98. AstraZeneca New Drug for Alzheimer's Treatment Product
 Table 99. AstraZeneca Recent Developments/Updates
 Table 100. Green Valley Company Information
 Table 101. Green Valley Description and Business Overview
 Table 102. Green Valley New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 103. Green Valley New Drug for Alzheimer's Treatment Product
 Table 104. Green Valley Recent Developments/Updates
 Table 105. Vivoryon Company Information
 Table 106. Vivoryon Description and Business Overview
 Table 107. Vivoryon New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 108. Vivoryon New Drug for Alzheimer's Treatment Product
 Table 109. Vivoryon Recent Developments/Updates
 Table 110. Simcere Company Information
 Table 111. Simcere Description and Business Overview
 Table 112. Simcere New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 113. Simcere New Drug for Alzheimer's Treatment Product
 Table 114. Simcere Recent Developments/Updates
 Table 115. Johnson and Johnson Company Information
 Table 116. Johnson and Johnson Description and Business Overview
 Table 117. Johnson and Johnson New Drug for Alzheimer's Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 118. Johnson and Johnson New Drug for Alzheimer's Treatment Product
 Table 119. Johnson and Johnson Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. New Drug for Alzheimer's Treatment Distributors List
 Table 123. New Drug for Alzheimer's Treatment Customers List
 Table 124. New Drug for Alzheimer's Treatment Market Trends
 Table 125. New Drug for Alzheimer's Treatment Market Drivers
 Table 126. New Drug for Alzheimer's Treatment Market Challenges
 Table 127. New Drug for Alzheimer's Treatment Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of New Drug for Alzheimer's Treatment
 Figure 2. Global New Drug for Alzheimer's Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global New Drug for Alzheimer's Treatment Market Share by Type: 2023 & 2030
 Figure 4. AChE Target Product Picture
 Figure 5. Aβ Target Product Picture
 Figure 6. BChE Target Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global New Drug for Alzheimer's Treatment Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global New Drug for Alzheimer's Treatment Market Share by Application: 2023 & 2030
 Figure 10. Preclinical Stage
 Figure 11. Mild Cognitive Impairment Stage
 Figure 12. Dementia Stage
 Figure 13. Global New Drug for Alzheimer's Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global New Drug for Alzheimer's Treatment Market Size (2019-2030) & (US$ Million)
 Figure 15. Global New Drug for Alzheimer's Treatment Sales (2019-2030) & (K Dose)
 Figure 16. Global New Drug for Alzheimer's Treatment Average Price (US$/Dose) & (2019-2030)
 Figure 17. New Drug for Alzheimer's Treatment Report Years Considered
 Figure 18. New Drug for Alzheimer's Treatment Sales Share by Manufacturers in 2023
 Figure 19. Global New Drug for Alzheimer's Treatment Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest New Drug for Alzheimer's Treatment Players: Market Share by Revenue in New Drug for Alzheimer's Treatment in 2023
 Figure 21. New Drug for Alzheimer's Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global New Drug for Alzheimer's Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America New Drug for Alzheimer's Treatment Sales Market Share by Country (2019-2030)
 Figure 24. North America New Drug for Alzheimer's Treatment Revenue Market Share by Country (2019-2030)
 Figure 25. United States New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe New Drug for Alzheimer's Treatment Sales Market Share by Country (2019-2030)
 Figure 28. Europe New Drug for Alzheimer's Treatment Revenue Market Share by Country (2019-2030)
 Figure 29. Germany New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific New Drug for Alzheimer's Treatment Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific New Drug for Alzheimer's Treatment Revenue Market Share by Region (2019-2030)
 Figure 36. China New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America New Drug for Alzheimer's Treatment Sales Market Share by Country (2019-2030)
 Figure 44. Mexico New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa New Drug for Alzheimer's Treatment Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa New Drug for Alzheimer's Treatment Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE New Drug for Alzheimer's Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of New Drug for Alzheimer's Treatment by Type (2019-2030)
 Figure 54. Global Revenue Market Share of New Drug for Alzheimer's Treatment by Type (2019-2030)
 Figure 55. Global New Drug for Alzheimer's Treatment Price (US$/Dose) by Type (2019-2030)
 Figure 56. Global Sales Market Share of New Drug for Alzheimer's Treatment by Application (2019-2030)
 Figure 57. Global Revenue Market Share of New Drug for Alzheimer's Treatment by Application (2019-2030)
 Figure 58. Global New Drug for Alzheimer's Treatment Price (US$/Dose) by Application (2019-2030)
 Figure 59. New Drug for Alzheimer's Treatment Value Chain
 Figure 60. New Drug for Alzheimer's Treatment Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed

Description

The global New Drug for Alzheimer's Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for New Drug for Alzheimer's Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for New Drug for Alzheimer's Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of New Drug for Alzheimer's Treatment include Biogen, Eisai, Eli Lilly, Neurimmune, Roche, AstraZeneca, Green Valley, Vivoryon, Simcere, Johnson and Johnson, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for New Drug for Alzheimer's Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding New Drug for Alzheimer's Treatment.

The New Drug for Alzheimer's Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global New Drug for Alzheimer's Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the New Drug for Alzheimer's Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of New Drug for Alzheimer's Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3:  Sales, revenue of New Drug for Alzheimer's Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Industry: Pharma & Healthcare

Published: 2024-07-17

Pages: 84 Pages

Report ld: 3244481

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 2900.00

Multi Users License

USD 4350.00

Corporate Users License